Subclinical atrial fibrillation: A new entity and what it means?

Peter Ott

doi:10.1016/j.jelectrocard.2016.07.031

Subclinical atrial fibrillation: A new entity and what it means?

Peter Ott

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

New device technologies allow for detection of clinically silent atrial fibrillation. This new entity has been associated with increased risk for stroke, even if detected for only relatively brief time periods. Current practice guidelines do not provide recommendations on how to approach this new clinical entity.

Original language	English (US)
Pages (from-to)	773-774
Number of pages	2
Journal	Journal of Electrocardiology
Volume	49
Issue number	6
DOIs	https://doi.org/10.1016/j.jelectrocard.2016.07.031
State	Published - Nov 1 2016
Externally published	Yes

Keywords

Anticoagulation
Subclinical atrial fibrillation

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jelectrocard.2016.07.031

Cite this

@article{5d81e1974efe42cb9e5965a163861485,

title = "Subclinical atrial fibrillation: A new entity and what it means?",

abstract = "New device technologies allow for detection of clinically silent atrial fibrillation. This new entity has been associated with increased risk for stroke, even if detected for only relatively brief time periods. Current practice guidelines do not provide recommendations on how to approach this new clinical entity.",

keywords = "Anticoagulation, Subclinical atrial fibrillation",

author = "Peter Ott",

note = "Publisher Copyright: {\textcopyright} 2016 Elsevier Inc.",

year = "2016",

month = nov,

day = "1",

doi = "10.1016/j.jelectrocard.2016.07.031",

language = "English (US)",

volume = "49",

pages = "773--774",

journal = "Journal of Electrocardiology",

issn = "0022-0736",

publisher = "Churchill Livingstone",

number = "6",

}

TY - JOUR

T1 - Subclinical atrial fibrillation

T2 - A new entity and what it means?

AU - Ott, Peter

PY - 2016/11/1

Y1 - 2016/11/1

N2 - New device technologies allow for detection of clinically silent atrial fibrillation. This new entity has been associated with increased risk for stroke, even if detected for only relatively brief time periods. Current practice guidelines do not provide recommendations on how to approach this new clinical entity.

AB - New device technologies allow for detection of clinically silent atrial fibrillation. This new entity has been associated with increased risk for stroke, even if detected for only relatively brief time periods. Current practice guidelines do not provide recommendations on how to approach this new clinical entity.

KW - Anticoagulation

KW - Subclinical atrial fibrillation

UR - http://www.scopus.com/inward/record.url?scp=84994141140&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994141140&partnerID=8YFLogxK

U2 - 10.1016/j.jelectrocard.2016.07.031

DO - 10.1016/j.jelectrocard.2016.07.031

M3 - Article

C2 - 27554422

AN - SCOPUS:84994141140

SN - 0022-0736

VL - 49

SP - 773

EP - 774

JO - Journal of Electrocardiology

JF - Journal of Electrocardiology

IS - 6

ER -

Subclinical atrial fibrillation: A new entity and what it means?

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this